Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
basic toxicokinetics, other
Type of information:
other: Assessment from available information
Adequacy of study:
key study
Study period:
March - September 2012
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
test procedure in accordance with generally accepted scientific standards and described in sufficient detail

Data source

Reference
Reference Type:
other: Final report
Title:
Unnamed
Year:
2012

Materials and methods

Objective of study:
toxicokinetics
Test guideline
Qualifier:
no guideline required

Test material

Constituent 1
Chemical structure
Reference substance name:
1,3-diethyldiphenylurea
EC Number:
201-645-2
EC Name:
1,3-diethyldiphenylurea
Cas Number:
85-98-3
Molecular formula:
C17H20N2O
IUPAC Name:
1,3-diethyl-1,3-diphenylurea
Test material form:
solid: crystalline
Details on test material:
SMILES:c1(N(C(=O)N(c2ccccc2)CC)CC)ccccc1

Results and discussion

Applicant's summary and conclusion

Conclusions:
Overall low acute oral toxicity of Centralit was found, but the absorption to the mammalian body occurs. At lethal doses the Central nervous system disturbances, tremors, lethargy, tonic convulsions were seen. There are marked differences in toxicity between sexes, the males are much more resistant and they stand alive at doses which are distinctly lethal to females. If it could be by caused by differences in absorption is unknown.
Sex differences in susceptibility to toxic effects of Centralite were noted also in studies with repeated administration. In these the effect on neural system of animals is manifested as Straub phenomenon in first days of administration. This reaction is similar for animals after application of opiate substance, e.g. morphine. During next weeks of study, these changes were not observed any more, which can relate with adaptation of organism of treated animals to the test substance. Everything written above reads for females. In males no such distinct reaction was observed. But in both sexes the effect on liver weight and function, changes in some blood parameters and plasma enzymes were noted.
Administration of Centralit had no adverse effect to ability of male and female animals to successfully mate and produce viable offspring. No signs of any gonadotropic or mutagenic effects were found.

Finally it could be concluded that Centralit after oral administration is absorbed into body of animals, metabolized in liver and either per se or as metabolites is rapidly distributed to CNS. It is questionable if it could reach also the reproduction organs.
The absorption through skin or eye mucosa is much less probable. Respiratory tract absorption could occur but the efficiency of this process is not known.
No information was found about the metabolism and elimination of Centralit.